![[logo] US EPA](http://www.epa.gov/epafiles/images/logo_epaseal.gif){kind=logo}
International Symposium on Environmental Aspects of Pharmaceuticals and Personal Care Products (2004)
First
"Integral Virtual Symposium" of the American Chemical Society
[PDF,
1 pp., 59 KB]
Assessment and
Perspective Regarding the
ACS-EPA Integral Virtual Symposium on PPCPs [PDF,
4 pp., 80 KB]
Organized and Sponsored by:
American Chemical Society (Division of Environmental Chemistry)
and the
U.S. Environmental Protection Agency (Office of Research and Development,
Las Vegas, NV)
25-26 August 2004
228th American Chemical Society National Meeting
Philadelphia, PA
Organizers:
C.G. Daughton
T.L. Jones-Lepp
L.H. Keith
M.J.M. Wells
Below is the agenda for Wednesday's morning and afternoon virtual sessions (25 August 2004). Note that narrated presentations only exist for the first day of this 2-day symposium. There are two versions for each narrated presentation. The first version (which can be accessed via the links provided for each title below) was pre-recorded and submitted before the meeting date. The second version was recorded on-site for those presentations that were delivered live during the meeting. These live presentations can be accessed here: http://www.tntech.edu/wrc/PPCPWebcast/PPCP.htm.
| 8:00 a.m. | Pharmaceuticals in the environment: Overview of significance, concerns and solutions. C.G. Daughton [PPT, 54 pp., 7.5 MB] |
| 8:25 a.m. | Tracking the fate of PPCPs from sewage treatment plants into the aquatic and terrestrial environments.[note: the audio does not yet work on this presentation] C.D. Metcalfe, X.-S. Miao, C. Mimeault and V. Trudeau |
| 8:50 a.m. | Sorption onto sludge from municipal STPs: A relevant process for the removal of pharmaceuticals and musk fragrances? T. Ternes, D. Loeffler, T. Knacker, A.C. Alder, A. Joss and H. Siegrist |
| 9:15 a.m. | Occurrence, transport and attenuation of pharmaceutical residues in groundwater. T. Heberer, A. Mechlinski and B. Fanck |
| 9:40 a.m. | Water quality monitoring of pharmaceuticals and personal care products using passive samplers. D. Alvarez, T. Jones-Lepp, P.E. Stackelberg, J. Petty, J. Huckins, E.T. Furlong, S.D. Zaugg and M. Meyer (extended abstract) |
| 10:05 a.m. | Prioritization, modeling and monitoring of veterinary medicines in the UK environment. A.B.A. Boxall, L.A. Fogg, E.J. Pemberton, D.W. Kolpin and D.J. Baird |
| 10:30 a.m. | Elimination of a realistic mixture of antibiotics in biological sewage treatment and effects on resistant and non-resistant sewage sludge bacteria. K. Kümmerer, J. Unger, A. Brunswick-Tietze and J. Wiethan |
| 10:55 a.m. | Panel discussion. |
Session II
| 1:30 p.m. | Pharmaceuticals and personal care products in solids: Analysis and field results for sediment, soil and biosolid samples. E.T. Furlong, C.A. Kinney, I. Ferrer, S. Werner, J. Cahill and G. Ratterman |
| 1:55 p.m. | Evaluation of conventional and advanced treatment processes to remove endocrine disruptors and pharmaceutically active compounds. S. Snyder, P. Westerhoff, Y. Yoon, B. Vanderford and D. Rexing |
| 2:20 p.m. | Fate of antimicrobial compounds during wastewater treatment. J. Heidler and R.U. Halden |
| 2:45 p.m. | Use of metoprolol enantiomers to discriminate between combined sewer overflows and wastewater effluent discharges. D.L. Sedlak |
| 3:10 p.m. | Contribution of photochemistry to the fate of pharmaceuticals and personal care products in surface waters. W.A. Arnold and K. McNeill |
| 3:35 p.m. | Human pharmaceuticals, hormones, antioxidants and plasticizers in wastewater treatment plant and water reclamation plant effluents. M.A. Soliman, J.A. Pedersen, H. Park, A. Castaneda-Jimenez, M.K. Stenstrom and I.H. Suffet [note: this presentation is not available with audio narration] |
| 4:00 p.m. | Beyond detection: Aquatic fate and effects of select ß-adrenergic blockers and serotonin selective reuptake inhibitors. B.W. Brooks, J.K. Stanley, E. Glidewell, A. Ramirez, T. Fadelu, R.D. Massengale, M. Mottaleb and C.K. Chambliss. |
| 4:25 p.m. | Panel discussion. |